In cancer progression, lncRNAs could orchestrate GSH dynamics by regulating NRF2-targeted antioxidant genes and GPX4 expression, respectively, thereby influencing oxidative stress adaptation and tumor growth. The gene discussed is NFE2L2; the disease is cancer.